Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Oncology Reports|August 24, 2013
Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survivalGuifang Lu, Tao Shan, Shuixiang He, et al.Developmental Science|June 21, 2023
Associations between infant amygdala functional connectivity and social engagement following a stressor: A preliminary investigationYannan Hu, Haitao Chen, Xiaomei Li, et al.Cerebral Cortex (New York, N.Y. : 1991)|April 6, 2023
Functional neural network connectivity at 3 months predicts infant-mother dyadic flexibility during play at 6 monthsXiaomei Li, Haitao Chen, Yannan Hu, et al.BMC Public Health|August 26, 2016
Did the English strategy reduce inequalities in health? A difference-in-difference analysis comparing England with three other European countriesYannan Hu, Frank J van Lenthe, Ken Judge, et al.FEBS Letters|November 15, 2011
Specificities of Ricinus communis agglutinin 120 interaction with sulfated galactoseYufeng Wang, Guangli Yu, Zhangrun Han, et al.Horticulture Research|March 20, 2023
Understanding water conservation vs. profligation traits in vegetable legumes through a physio-transcriptomic-functional approachPingping Fang, Ting Sun, Arun Kumar Pandey, et al.Journal of Agricultural and Food Chemistry|December 22, 2022
Transcriptome Dynamics of Common Bean Roots Exposed to Various Heavy Metals Reveal Valuable Target Genes and Promoters for Genetic EngineeringPingping Fang, Yannan Hu, Wenjun Xia, et al.Psychoneuroendocrinology|March 17, 2026
Personality traits modulate temporal dynamics and cross-system coordination of acute stress responses in virtual realityHao Xu, Jie Huang, Mengzhuang Gou, et al.Current Medical Research and Opinion|December 11, 2023
A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myelomaIsha Mol, Yannan Hu, Thomas W LeBlanc, et al.Leukemia & Lymphoma|February 13, 2024
A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myelomaIsha Mol, Yannan Hu, Thomas W LeBlanc, et al.Pageof 5